Kangmei Pharma | 600518 - Bruttoergebnis Vom Umsatz





Bruttoergebnis Vom Umsatz Veränderung Datum
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Avita Medical AUD 14.31M 639K 2025-12
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Dianthus Therapeutics USD 284K 112K 2025-12
Genomma Lab Internacional MXN 2.66B 208.35M 2026-03
Hypermarcas BRL 1.38B 16.08M 2025-12
Ionis Pharmaceuticals USD 243M 48M 2026-03
IQVIA Holdings USD 1.07B 52M 2026-03
Jiangsu Hengrui CNY 7.27B 918.27M 2025-12
Kangmei Pharma CNY 238.34M 31.95M 2026-03
Moderna USD -566M 792M 2026-03
Organon & Co USD 854M 3M 2025-12
Revvity USD 387.66M 34M 2026-03
Sh Fosun Pharma CNY 6.69B 1.9B 2025-12
Tectonic Therapeutic USD 0 0 2025-03
Viatris USD 1.38B 229.9M 2026-03
Wuxi Apptec CNY 6.27B 68.16M 2026-03
Xeris Pharmaceuticals USD 72.15M 8.77M 2025-12
Zz Pientze Pharmaceu CNY 1.16B 860.2M 2026-03